EcoDrugPlus

Transthyretin

Ensembl ID : ENSPTIG00000012195
Gene Symbol: TTR
2 Cross references
164 Possible Orthologues:

Tryptophan Hydroxylase 1

Ensembl ID : ENSPTIG00000019857
Gene Symbol: TPH1
2 Cross references
255 Possible Orthologues:

Tubulin Alpha 4a

Ensembl ID : ENSPTIG00000021758
Gene Symbol: TUBA4A
2 Cross references
224 Possible Orthologues:

Tubulin Beta 2a Class Iia

Ensembl ID : ENSPTIG00000019182
Gene Symbol: TUBB2A
2 Cross references
181 Possible Orthologues:

Tubulin Beta 3 Class Iii

Ensembl ID : ENSPTIG00000012105
Gene Symbol: TUBB3
2 Cross references
144 Possible Orthologues:

Tubulin Beta 4b Class Ivb

Ensembl ID : ENSPTIG00000009535
Gene Symbol: TUBB4B
2 Cross references
318 Possible Orthologues:

Tubulin Beta 6 Class V

Ensembl ID : ENSPTIG00000012075
Gene Symbol: TUBB6
2 Cross references
141 Possible Orthologues:

Tubulin Beta Class I

Ensembl ID : ENSPTIG00000006316
Gene Symbol: TUBB
2 Cross references
333 Possible Orthologues:

Tumor Protein P53

Ensembl ID : ENSPTIG00000020802
Gene Symbol: TP53
2 Cross references
253 Possible Orthologues:

Tyrosinase

Ensembl ID : ENSPTIG00000014539
Gene Symbol: TYR
2 Cross references
266 Possible Orthologues:

Tyrosine Hydroxylase

Ensembl ID : ENSPTIG00000006730
Gene Symbol: TH
2 Cross references
187 Possible Orthologues:

Tyrosine Kinase 2

Ensembl ID : ENSPTIG00000008529
Gene Symbol: TYK2
2 Cross references
196 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects from the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).